Current Drug Targets
Volume 23, 17 Issues, 2022
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
Contents
Current Drug Targets , Volume 10 - Number 1
NPY Signalling Pathway in Bone Homeostasis: Y1 Receptor as a Potential Drug Target
, 10(1): 9 - 19D. M. Sousa, H. Herzog and M. Lamghari
DOI: 10.2174/138945009787122888
Role of ARBs in the Blood Hypertension Therapy and Prevention of Cardiovascular Events
, 10(1): 20 - 25S. Novo, M. Lunetta, S. Evola and G. Novo
DOI: 10.2174/138945009787122897
Monoclonal Antibodies in the Treatment of Systemic Lupus Erythematosus
, 10(1): 26 - 37Ewa Robak and Tadeusz Robak
DOI: 10.2174/138945009787122833
PDGF-D Signaling: A Novel Target in Cancer Therapy
, 10(1): 38 - 41Zhiwei Wang, Dejuan Kong, Yiwei Li and Fazlul H. Sarkar
DOI: 10.2174/138945009787122914
Interactions Between Advanced Glycation End-Products (AGE) and their Receptors in the Development and Progression of Diabetic Nephropathy â are these Receptors Valid Therapeutic Targets
, 10(1): 42 - 50Karly C. Sourris and Josephine M. Forbes
DOI: 10.2174/138945009787122905
Pathophysiology of Sepsis in the Elderly: Clinical Impact and Therapeutic Considerations
, 10(1): 60 - 70A. R. De Gaudio, S. Rinaldi, C. Chelazzi and T. Borracci
DOI: 10.2174/138945009787122879
Emerging Drug Candidates of Dipeptidyl Peptidase IV (DPP IV) Inhibitor Class for the Treatment of Type 2 Diabetes
, 10(1): 71 - 87Rajesh Gupta, Sameer S. Walunj, Ranjeet K. Tokala, Kishore V.L. Parsa, Santosh Kumar Singh and Manojit Pal
DOI: 10.2174/138945009787122860
Editor-in-Chief
Francis J. Castellino
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
COPE Compliant
About the Journal
⇨ Journal Home⇨ Editorial Policies⇨ Fabricating and Stating False Information⇨ Research Misconduct⇨ Allegations from Whistleblowers⇨ Editorial Board⇨ Meet the Executive Guest Editor(s)⇨ Board Recruitment Workflow⇨ Join Editorial Board⇨ Indexing Information⇨ Announcements⇨ Endorsements⇨ Authors' Comments⇨ Special Offers
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.
Webmaster Contact: info@benthamscience.net